Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
cefazolin interleukin-15 small molecule NA drugbank Operative Surgical Procedures[MeSHID:D013514]
Stomach[MeSHID:D013270]
Bacterial Infections[MeSHID:D001424]
Blood[MeSHID:D001769]
Skin Diseases
Bacterial[MeSHID:D017192]
Heart Valves[MeSHID:D006351]
Lung[MeSHID:D008168]
Urinary tract[MeSHID:D014551]
Bone Tissue[MeSHID:D001842]
Infection[MeSHID:D007239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cefazolin interleukin-2 small molecule NA drugbank Operative Surgical Procedures[MeSHID:D013514]
Stomach[MeSHID:D013270]
Bacterial Infections[MeSHID:D001424]
Blood[MeSHID:D001769]
Skin Diseases
Bacterial[MeSHID:D017192]
Heart Valves[MeSHID:D006351]
Lung[MeSHID:D008168]
Urinary tract[MeSHID:D014551]
Bone Tissue[MeSHID:D001842]
Infection[MeSHID:D007239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
cefazolin serum paraoxonase/arylesterase 1 small molecule NA drugbank Operative Surgical Procedures[MeSHID:D013514]
Stomach[MeSHID:D013270]
Bacterial Infections[MeSHID:D001424]
Blood[MeSHID:D001769]
Skin Diseases
Bacterial[MeSHID:D017192]
Heart Valves[MeSHID:D006351]
Lung[MeSHID:D008168]
Urinary tract[MeSHID:D014551]
Bone Tissue[MeSHID:D001842]
Infection[MeSHID:D007239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved inhibitor
click here to return to the previous page